Literature DB >> 12195704

Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor.

Annapaola Andolfo1, William R English, Massimo Resnati, Gillian Murphy, Francesco Blasi, Nicolai Sidenius.   

Abstract

Proteolytic cleavage of the urokinase plasminogen activator receptor (uPA(R)) prevents the binding of uPA and vitronectin while generating biologically active uPAR fragments. We have recently shown that matrix metalloproteinase-12 (MMP-12) releases cellular uPAR-antigen from stimulated human micro-vascular endothelial cells providing a novel feedback mechanism between the plasminogen activation and MMP systems. We now show that MMP-12 and other MMPs directly and efficiently cleave uPAR at the Thr86 paralal Tyr87 peptide bond located in the linker region connecting uPAR domains 1 and 2, releasing the major ligand binding domain 1 from the rest of the receptor. The possible biological importance of uPAR cleavage by MMPs is supported by the observation that also murine uPAR is cleaved by MMP-12 (at the Pro89 paralal Gln90 peptide bond), despite the limited sequence homology between the linker regions. Using an antibody raised against the human uPAR linker region we show that this region of uPAR, which contains the chemotactic SRSRY epitope, is exposed upon MMP cleavage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195704

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  26 in total

1.  Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

Authors:  Cyril Barinka; Graham Parry; Jennifer Callahan; David E Shaw; Alice Kuo; Khalil Bdeir; Douglas B Cines; Andrew Mazar; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

Review 2.  Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting.

Authors:  Georgina S Butler; Christopher M Overall
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

Review 3.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

Review 4.  Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.

Authors:  Beate Heissig; Douaa Dhahri; Salita Eiamboonsert; Yousef Salama; Hiroshi Shimazu; Shinya Munakata; Koichi Hattori
Journal:  Cell Mol Life Sci       Date:  2015-09-09       Impact factor: 9.261

5.  Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.

Authors:  Sean T Zuckerman; James F Brown; Weiyuan J Kao
Journal:  Biomaterials       Date:  2009-05-14       Impact factor: 12.479

Review 6.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

7.  Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells.

Authors:  Marc Tjwa; Nicolai Sidenius; Rute Moura; Sandra Jansen; Koen Theunissen; Annapaola Andolfo; Maria De Mol; Mieke Dewerchin; Lieve Moons; Francesco Blasi; Catherine Verfaillie; Peter Carmeliet
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

8.  Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis.

Authors:  Boris K Pliyev; Mikhail Yu Menshikov
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

9.  Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.

Authors:  Orla Cunningham; Annapaola Andolfo; Maria Lisa Santovito; Lucia Iuzzolino; Francesco Blasi; Nicolai Sidenius
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

10.  Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.

Authors:  Georgina S Butler; Richard A Dean; Eric M Tam; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.